0001610717-23-000288.txt : 20230919
0001610717-23-000288.hdr.sgml : 20230919
20230919161702
ACCESSION NUMBER: 0001610717-23-000288
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230915
FILED AS OF DATE: 20230919
DATE AS OF CHANGE: 20230919
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Horn Margaret A
CENTRAL INDEX KEY: 0001294192
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39219
FILM NUMBER: 231264003
MAIL ADDRESS:
STREET 1: 925 PAGE MILL ROAD
CITY: PALO ALTO
STATE: CA
ZIP: 94304
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Revolution Medicines, Inc.
CENTRAL INDEX KEY: 0001628171
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 472029180
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 700 SAGINAW DR
CITY: REDWOOD CITY
STATE: CA
ZIP: 94063
BUSINESS PHONE: 415-766-3638
MAIL ADDRESS:
STREET 1: 700 SAGINAW DR
CITY: REDWOOD CITY
STATE: CA
ZIP: 94063
4
1
form4.xml
X0508
4
2023-09-15
0001628171
Revolution Medicines, Inc.
RVMD
0001294192
Horn Margaret A
C/O REVOLUTION MEDICINES, INC.
700 SAGINAW DRIVE
REDWOOD CITY
CA
94063
true
Chief Operating Officer
true
Common Stock
2023-09-15
4
M
0
5000
4.09
A
104474
D
Common Stock
2023-09-15
4
S
0
5000
32.0817
D
99474
D
Common Stock
2023-09-18
4
S
0
2514
31.3105
D
96960
D
Stock Option (Right to Buy)
4.09
2023-09-15
4
M
0
5000
0
D
2023-03-13
2029-03-12
Common Stock
5000
103302
D
Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on March 29, 2023.
Includes 64,875 restricted stock units ("RSUs").
This transaction was executed in multiple trades in prices ranging from $31.60 to $32.51, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.
Pursuant to an automatic sell-to-cover imposed by the terms of the RSUs award, the shares were sold following the vesting of the RSUs solely to cover applicable withholding taxes.
This transaction was executed in multiple trades in prices ranging from $31.1010 to $31.3108, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.
/s/ Jack Anders, as Attorney-in-fact for Margaret Horn
2023-09-19